BCAX vs PG · $1.51B cap vs P/E 25, rev $84.28B
Bicara Therapeutics Inc. Common Stock (BCAX) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Bicara Therapeutics Inc. Common Stock (BCAX) is a biotechnology company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
BCAX does not have a complete income-statement cache yet.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
BCAX currently screens at market cap $1.51B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the BCAX and PG stock pages for the full models.
Not investment advice.